Today's Stock Analyst Initiations and New Coverage

Track the latest stock analyst initiations, newly initiated coverage, and first-time analyst ratings in this regularly updated list of analyst recommendations. This page compiles new initiations, including initial stock ratings, buy/hold/sell recommendations, and price targets, so you can monitor all recent coverage openings across the market.

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
CHCT Community Healthcare Trust	Initiated by	Huntington Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.80 +1.2%	$20.00	Outperform
DINO HF Sinclair	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$88.56 +2.0%	$85.00	In-Line
EAT Brinker International	Initiated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$189.28 +2.1%	$220.00	Overweight
FCBM First Carolina Financial Services	Initiated by	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.78 -0.2%	$14.00	Market Perform
FSLY Fastly	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Almas Almaganbetov Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.72 +2.0%	$27.00	Buy
GEHC GE HealthCare Technologies	Initiated by	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$63.07 -4.0%	$14.00	Market Perform
IVA Inventiva	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Prakhar Agrawal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.62 +2.2%		Overweight
MCO Moody's	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Surinder Thind Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$511.15 -1.5%	$610.00	Buy
MSCI MSCI	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Surinder Thind Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$628.83 -1.3%	$760.00	Buy
NEPH Nephros	Initiated by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.78 +0.5%	$4.00	Market Perform
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad) Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.
NFLX Netflix	Initiated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$68.95 -7.3%		Overweight
NHP National Healthcare Properties	Initiated by	Huntington Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.86 +1.9%	$18.00	Outperform
OMDA Omada Health	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Larsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.70 +0.1%	$30.00	Buy
PBF PBF Energy	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$62.63 +2.8%	$58.00	In-Line
ZNTL Zentalis Pharmaceuticals	Initiated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Graig Suvannavejh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.11 +11.8%	$8.00	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 09:58 PM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Analyst Initiations

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Analyst Initiations

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools